Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
209.92
USDSponsored
+7.09
+3.50%
Sep 02, 15:57 UTC -4
Closed
Pre-Market
208.99
-0.93
-0.44%
AXSM Earnings Reports
Positive Surprise Ratio
AXSM beat 21 of 43 last estimates.
49%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$263.12M
/-$0.40
Implied change from Q2 26 (Revenue/ EPS)
+20.49%
/-59.60%
Implied change from Q3 25 (Revenue/ EPS)
+53.88%
/-57.45%
Axsome Therapeutics, Inc earnings per share and revenue
On Aug 10, 2026, AXSM reported earnings of -0.99 USD per share (EPS) for Q2 26, missing the estimate of -0.86 USD, resulting in a -14.90% surprise. Revenue reached 218.38 million, compared to an expected 225.65 million, with a -3.23% difference. The market reacted with a +3.83% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 263.12 million USD, implying an decrease of -59.60% EPS, and increase of 20.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-Surprise
-
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-Actual
-$0.35
Surprise
-
FAQ
What were Axsome Therapeutics, Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Axsome Therapeutics, Inc reported EPS of -$0.99, missing estimates by -14.9%, and revenue of $218.38M, -3.23% below expectations.
How did the market react to Axsome Therapeutics, Inc's Q2 2026 earnings?
The stock price moved up 3.83%, changed from $212.74 before the earnings release to $220.89 the day after.
When is Axsome Therapeutics, Inc expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Axsome Therapeutics, Inc's next earnings report?
Based on 13
analysts, Axsome Therapeutics, Inc is expected to report EPS of -$0.40 and revenue of $263.12M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement